Gritstone bio (GRTS) Net earnings per share growth forecast for next year

Symbol and logo of brand Gritstone bio, Inc. (GRTS)

This chart of expected EPS growth for the coming year visualizes the Gritstone bio, Inc. (GRTS) strategy of developing RNA vaccines through partnerships and the EDGE AI platform. The process is accelerating via the implementation of automated synthesis stations, while leading immunologists drive development. The current value of 8.40 expresses the metric level, consolidating complex Wall Street expert models into a single line to assess future earnings.

GRTS - Gritstone Bio Earnings growth forecast for next year over the range 07/04/2022 - 11/02/2024

Metric breakdowns and analytics for Gritstone bio, Inc. (GRTS)

- price and consensus price forecast:
Analysis of all company metrics:Gritstone bio, Inc.
Core merchandise of Gritstone Bio

This indicator determines investment reliability by calculating the percentage change in expected net profit for the coming year, allowing investors to identify the gap between market expectations and the actual trend. By analyzing the history of consensus estimates for next year's profit dynamics, one can assess the capitalization potential of Gritstone bio, Inc. (GRTS), whose success depends on the effectiveness of developments by elite onco-immunologists in the field of personalized mRNA vaccines.

Direct competitors

Net earnings per share growth forecast for next year immunitybio.com|Expected earnings per share growth for next year immunocore.com (IMCR)|Net earnings per share growth forecast for next year Janux Therapeutics Inc (JANX)|Expected earnings per share growth for next year Arcus Bio RCUS|Zymeworks Inc - Expected earnings per share growth for next year|Earnings growth forecast for next year Tango Therapeutics Corp TNGX|IOVA - Net earnings per share growth forecast for next year|IMTX (immatics.com) - Projected earnings per share growth rate for next year|Xencor Inc. (XNCR) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Compass Bio (CMPX)|Expected earnings per share growth for next year REPL|LYEL - Net earnings per one share growth forecast for next year|Expected earnings per share growth for next year IPHA (Innate Pharma, S.A.)|Projected earnings per share increase next year PYXS|Earnings growth forecast for next year CGEN (Compugen Ltd.)|Expected earnings per share trend next year IOBT|sutrobio.com - Earnings growth forecast for next year|Expected net earnings per share growth next year MiNK Therapeutics, Inc|Werewolf (HOWL) - Net earnings per share growth forecast for next year|Immix Biopharma Inc. - Expected earnings per share trend next year|ALXO (alxoncology.com) - Earnings growth forecast for next year|Cue Biopharma, Inc. - Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year pdsbiotech.com (PDSB)|SONN: Net earnings per share change forecast for next year|MAIA Biotech - Expected earnings per share growth for next year|liminatuspharma.com (LIMN) - Expected net earnings per share growth next year|LVTX - Net earnings per share growth forecast for next year|NXTC (NextCure) - Projected earnings per share growth rate for next year|LPTX: Earnings growth forecast for next year|Projected earnings per share growth rate for next year INTS|Net earnings per share growth forecast for next year Sensei Biotherapeutics, Inc.|Expected net earnings per share growth next year therivabio.com TOVX|Earnings growth forecast for next year KA|Consensus forecast of earnings per share growth for next year NexImmune Inc|Net earnings per share growth forecast for next year turnstonebio.com TSBX|Consensus forecast of earnings per share growth for next year Vaccinex Inc (VCNX)|HARP - Net earnings per share growth forecast for next year